Table 6.
Comparison of the co-morbidities present in the two groups
Co-morbid | Number in cisplatin group (%) | Number in noncisplatin group (%) |
---|---|---|
N = 200 | N = 200 | |
Diabetes Mellitus | 30 (15) | 24 (12) |
Hypertension | 46 (23) | 52 (26) |
Coronary artery disease | 10 (5) | 08 (4) |
Prior Atrial fibrillation | 04 (2) | 04 (2) |
Prior history of TIA/Stroke | 02 (1) | 00 |
Renal Failure | 00 | 00 |
Heart Failure | 00 | 00 |